Status:

ACTIVE_NOT_RECRUITING

The Impact of Psychosocial Interventions in Patients with COPD

Lead Sponsor:

University of Crete

Conditions:

Chronic Obstructive Pulmonary Disease (COPD)

Eligibility:

All Genders

Phase:

NA

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is one of the most common exacerbating, non-communicable diseases. It is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. G...

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is one of the most common exacerbating, non-communicable diseases. It is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. G...

Eligibility Criteria

Inclusion

  • Adult patients with a confirmed diagnosis of COPD.
  • Participants should be attended by the above healthcare departments in the Heraklion Prefecture.
  • Know the Greek dialect.
  • Have the ability to sign a consent form.

Exclusion

  • Patients with severe and/or mental disorders.
  • Patients with severe mental disability or advanced neurodegenerative disease. - Patients who do not wish to participate.

Key Trial Info

Start Date :

September 8 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 28 2026

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT06599177

Start Date

September 8 2024

End Date

February 28 2026

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Crete

Heraklion, Crete, Greece, 71003